Your browser doesn't support javascript.
loading
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Cerna, Karin; Duricova, Dana; Lukas, Martin; Kolar, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kostrejova, Marta; Jirsa, Jakub; Kastylova, Kristyna; Peterka, Stepan; Vojtechova, Gabriela; Lukas, Milan.
Afiliação
  • Cerna K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Duricova D; GENNET, Prague, Czech Republic.
  • Lukas M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Kolar M; Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Machkova N; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Hruba V; Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov, Czech Republic.
  • Mitrova K; Department of Surgery, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Kubickova K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Kostrejova M; Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Libechov, Czech Republic.
  • Jirsa J; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Kastylova K; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Peterka S; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Vojtechova G; Department of Pediatrics, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Lukas M; Clinical and Research Center for Inflammatory Bowel Disease ISCARE and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Crohns Colitis 360 ; 5(4): otad040, 2023 Oct.
Article em En | MEDLINE | ID: mdl-38028954
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Crohns Colitis 360 Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Crohns Colitis 360 Ano de publicação: 2023 Tipo de documento: Article